Biotronik SE & Co KG (Biotronik) is a medical device company that develops, manufactures, and distributes cardiovascular and endovascular solutions. The company’s cardiac rhythm management solutions include implantable devices, leads, and accessories and external devices to treat and manage arrhythmia-related diseases. Its electrophysiology products include heart catheters used to diagnose and treat cardiac arrhythmias; and vascular intervention products such as stent systems, balloon catheters, and guide wires for the treatment of peripheral, and coronary artery diseases. Biotronik has manufacturing facilities in Germany, Singapore, Switzerland, and the US. Biotronik is headquartered in Berlin, Germany.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biotronik SE & Co KG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Biotronik SE & Co KG Company Overview
- Biotronik SE & Co KG Company Snapshot
- Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
- Biotronik SE & Co KG - Pipeline Analysis Overview
- Business Description
- Biotronik SE & Co KG - Key Facts
- Biotronik SE & Co KG - Major Products and Services
- Biotronik SE & Co KG Pipeline Products by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG Pipeline Products Overview
- AI Based Telemedicine - Myocardial Infarction
- AI Based Telemedicine - Myocardial Infarction Product Overview
- Allevia
- Allevia Product Overview
- AMS-2
- AMS-2 Product Overview
- Amvia Stellar
- Amvia Stellar Product Overview
- BIOVALVE Resheathable Transcatheter Aortic Valve
- BIOVALVE Resheathable Transcatheter Aortic Valve Product Overview
- Coronary Stent System
- Coronary Stent System Product Overview
- CorSky Device
- CorSky Device Product Overview
- CorSky Device Clinical Trial
- Delivr
- Delivr Product Overview
- DREAMS 3G System
- DREAMS 3G System Product Overview
- DREAMS 3G System Clinical Trial
- ElePulse System
- ElePulse System Product Overview
- ElePulse System Clinical Trial
- Freesolve BTK RMS
- Freesolve BTK RMS Product Overview
- Freesolve BTK RMS Clinical Trial
- Hatriq
- Hatriq Product Overview
- Implantable Pressure Sensor
- Implantable Pressure Sensor Product Overview
- ProGenic Pimecrolimus-eluting Coronary Stent System
- ProGenic Pimecrolimus-eluting Coronary Stent System Product Overview
- Solvia Rise
- Solvia Rise Product Overview
- Solvia Rise Clinical Trial
- Truvia
- Truvia Product Overview
- Biotronik SE & Co KG - Key Competitors
- Biotronik SE & Co KG - Key Employees
- Biotronik SE & Co KG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biotronik SE & Co KG, Recent Developments
- Jun 04, 2025: First Patient Enrolled in Leave Nothing Behind-Trial Comparing Drug-Coated Balloon-Based Strategy to Drug-Eluting Stents in Chronic Total Occlusion Patients
- May 21, 2025: BIOMAG-I Data Shows No New Events between Two and Three Years in Target Lesion Failure with Freesolve Resorbable Magnesium Scaffold
- Apr 24, 2025: Implicity's EVIDENCE-RM Study Demonstrates Marked Improvement in ICD Patient Outcomes
- Apr 23, 2025: Biotronik Received Additional HDE Clearance for PK Papyrus Covered Coronary Stent
- Apr 15, 2025: Biotronik Obtains Additional HDE Clearance for PK Papyrus Covered Coronary Stent
- Apr 15, 2025: Biotronik Receives an Additional 510(K) Clearance For Pantera Pro Coronary Dilatation Catheter
- Apr 15, 2025: Biotronik Receives an Additional 510(K) Clearance For Pantera LEO Coronary Dilatation Catheter
- Apr 15, 2025: Biotronik Receives Additional 510(K) Clearance For Passeo-35 Xeo PTA Balloon Catheter
- Apr 15, 2025: Biotronik Receives Additional 510(K) Clearance For Oscar Peripheral Multifunctional Catheter System
- Mar 14, 2025: Biotronik Receives Additional HDE Clearance for PK Papyrus Covered Coronary Stent
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Biotronik SE & Co KG Pipeline Products and Ongoing Clinical Trials Overview
- Biotronik SE & Co KG Pipeline Products by Equipment Type
- Biotronik SE & Co KG Pipeline Products by Indication
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG, Key Facts
- Biotronik SE & Co KG, Major Products and Services
- Biotronik SE & Co KG Number of Pipeline Products by Development Stage
- Biotronik SE & Co KG Pipeline Products Summary by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
- Biotronik SE & Co KG Ongoing Clinical Trials Summary
- AI Based Telemedicine - Myocardial Infarction - Product Status
- AI Based Telemedicine - Myocardial Infarction - Product Description
- Allevia - Product Status
- Allevia - Product Description
- AMS-2 - Product Status
- AMS-2 - Product Description
- Amvia Stellar - Product Status
- Amvia Stellar - Product Description
- BIOVALVE Resheathable Transcatheter Aortic Valve - Product Status
- BIOVALVE Resheathable Transcatheter Aortic Valve - Product Description
- Coronary Stent System - Product Status
- Coronary Stent System - Product Description
- CorSky Device - Product Status
- CorSky Device - Product Description
- CorSky Device - BIO|CONCEPT.CorSky Family, First in Human Study for the CorSky ICD Family
- Delivr - Product Status
- Delivr - Product Description
- DREAMS 3G System - Product Status
- DREAMS 3G System - Product Description
- DREAMS 3G System - 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Drug Eluting Stents in Patients With Non ST-segment Elevation Acute Coronary Syndromes: the RESORB-ACS Randomized Clinical Trial
- DREAMS 3G System - BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Resorbable Coronary MAGnesium Scaffold System (DREAMS 3G) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries: BIOMAG-II: A Randomized Controlled Trial
- DREAMS 3G System - Hybrid Percutaneous Coronary Intervention Combining A Bioresorbable Scaffold With Drug-Coated Balloons Versus A Conventional Drug-Eluting Stent-Based Strategy In Patients With Long And Diffuse Coronary Artery Disease: The Biohybrid Randomized Pilot Trial
- ElePulse System - Product Status
- ElePulse System - Product Description
- ElePulse System - Rapid One-Shot Electroporation Trial For Atrial Fibrillation: Reset-AF: Investigating the Effect of A Novel Intervention on Atrial Fibrillation Recurrence
- Freesolve BTK RMS - Product Status
- Freesolve BTK RMS - Product Description
- Freesolve BTK RMS - The Prospective, Single-Center, Single-Blind, Randomized Trial To Evaluate the Efficacy of the Pantera Lux DCB and Freesolve RMS Compared to Orsiro Mission DES
- Hatriq - Product Status
- Hatriq - Product Description
- Implantable Pressure Sensor - Product Status
- Implantable Pressure Sensor - Product Description
- ProGenic Pimecrolimus-eluting Coronary Stent System - Product Status
- ProGenic Pimecrolimus-eluting Coronary Stent System - Product Description
- Solvia Rise - Product Status
- Solvia Rise - Product Description
- Solvia Rise - BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
- Truvia - Product Status
- Truvia - Product Description
- Biotronik SE & Co KG, Key Employees
- Biotronik SE & Co KG, Subsidiaries
- Glossary
- Biotronik SE & Co KG Pipeline Products by Equipment Type
- Biotronik SE & Co KG Pipeline Products by Development Stage
- Biotronik SE & Co KG Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic Plc
- Medico SPA
- Acandis GmbH & Co KG
- Abbott Laboratories
- Eurocor Tech GmbH
